Catalysis is an enabling technology for the worldwide production of a vast majority of fuels and chemicals. The catalysis division of our group seeks to understand reaction mechanisms and elucidate design principles in both homogeneous and heterogeneous catalysis. Our current interests cover biomass conversion and synthesis of pharmaceuticals. Conversion of biomass to valuable chemicals is an important aspect of long-term sustainability goals. We apply isotopic labeling, reaction kinetics and a variety of catalyst characterization tools, while collaborating on computational modeling to develop mechanism proposals that guide future catalyst optimization.
Rooted in Dr. Allgeier's two decades of industrial experience, our group has particular expertise in elucidating mechanisms of catalyst deactivation and developing strategies to extend the useful life of catalysts. These interests encompass applications of high-cost, specialized catalysts used in the pharmaceutical industry. To improve the sustainability of catalysis in pharma applications, we also seek to convert catalytic transformations from precious metal catalysts to earth abundant metal catalysts in continuous flow processes.